By contrastsecretion rates to forskolin that happen to be CFTR-dependent were much larger in scausing

By the present approach, it is not quite feasible to attribute these proteomic changes to one or another individual species, so at this stage they would have to be considered as a universal biofilm shift. Of note, fructose 1,6-bisphophate metabolism and carbohydrate metabolism were 2 of the 5 biological processes shared between these two kinds of biofilm variants. These two GO entities, together with glycolytic process, galactose metabolism, and arginine biosynthetic process, were enriched in absence of A. actinomycetemcomitans, indicating a strong alternation in the metabolic pathways of the biofilm. This may not be surprising, as for example, A. actinomycetemcomitans may utilize lactate from streptococci as energy source. On the other hand, many glucose transports in A. actinomycetemcomitans can also be inhibited, as consequence of using lactate as carbon source. These inhibited processes include a phosphoenolpyruvate : carbohydrate phosphotransferase system, a bacterial unique system for concomitant transport and phosphorylation of carbohydrates in many species. Among all our identified proteins, 2, 4, 12, 7, and 1 PTS proteins were identified from A. actinomycetemcomitans, F. nucleatum, S. anginosus, S. oralis, V. dispar, respectively, while based on the label-free data, all the non-A. actinomycetemcomitans PST proteins were identified as S. anginosus-derived, with 1 un-regulated and 4 downregulated proteins. Regulation of these proteins definitely affected the output of the related GO function categories. Apart from direct effects of the PST regulation, other driving forces of selecting different organisms as consequence of A. actinomycetemcomitans utilizing lactate from streptococci, including shifts in pH and regulating quorum sensing factor AI-2 by PTS, may also contribute in biofilm formation and growth. In the context of a multiple species biofilm, such as the one used in this study, all the interactions between species become very complex and intricate. Therefore, understanding these interactions as a whole unit is not only more biologically reliable, but also a more efficient way to start deciphering biologically meaningful explanations. The cellular localization category analysis for the most up- or down- regulated proteins delivered fractions associated with the intracellular/membrane component, with more than half of the identified GO terms falling into these categories. This indicated that A. actinomycetemcomitans could have a strong effect on mobilization of proteins in the bacterial cell compartments within the biofilm. Since by the present experimental approach we did not investigate the secreted protein fractions of the biofilm, it has not been possible to evaluate the overall turnover of extracellular proteins in the biofilm. Elucidating the roles of specific bacterial species in a multiple species biofilm is a hard but eventually necessary task in understanding a biofilm as a community. The updated proteomic technologies provide powerful tools to understanding biofilms in a more detailed manner than earlier approaches. Rather than identifying a panacea for the control of oral biofilms, the present study revealed shifts in the proteomic composition and functions within a complex in vitro biofilm environment, particularly focusing on the ecological pressures exerted by A. actinomycetemcomitans in the remainders of the bacterial community. On a further step, this type of analysis might be more meaningful if combined with a specific biological question, or in a co-culture system with host tissues, where one can more clearly predict the specific bacterial proteins in relation to their healthy or deleterious impact on the human host. The cardinal manifestations of Parkinson’s disease are caused by the degeneration of dopaminergic neurons of the substantia nigra, which leads to a deficit of dopamine in the striatum. Dopamine replacement therapy with L-3,4-dihydroxyphenylalanine is the most effective treatment for PD. However, long-term treatment with L-DOPA is associated with motor and non-motor complications, such as dyskinesia, wearing-OFF and hallucinations. The wearing-OFF Nutlin-3 phenomenon can be described as a shortening in the duration of anti-parkinsonian benefit, ON-time. Wearing-OFF typically begins after a few years of L-DOPA treatment, affecting 41% of patients after 5 years and more than 90% of PD patients after 15 years of dopaminergic therapy.

Latest comments

No comments